4//SEC Filing
Bigora Sian 4
Accession 0000897069-24-001615
CIK 0001533743other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 5:34 PM ET
Size
18.0 KB
Accession
0000897069-24-001615
Insider Transaction Report
Form 4
Bigora Sian
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2024-07-10$1.71/sh−225$385→ 21,878 total - Exercise/Conversion
Common Stock
2024-04-05+1,675→ 21,827 total - Tax Payment
Common Stock
2024-04-05$2.79/sh−368$1,027→ 21,459 total - Exercise/Conversion
Common Stock
2024-07-10+644→ 22,103 total - Award
Restricted Stock Units
2024-06-28+3,233→ 24,728 totalExercise: $0.00→ Common Stock (3,233 underlying) - Award
Restricted Stock Units
2024-06-28+404→ 27,961 totalExercise: $0.00→ Common Stock (404 underlying) - Award
Restricted Stock Units
2024-06-28+2,425→ 27,153 totalExercise: $0.00→ Common Stock (2,425 underlying) - Award
Restricted Stock Units
2024-06-28+404→ 27,557 totalExercise: $0.00→ Common Stock (404 underlying)
Holdings
- 6,668(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]Distribution of vested restricted shares.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on January 1, 2025.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027.
- [F4]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001799365
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 5:34 PM ET
- Size
- 18.0 KB